Israel Active

Prof Mahmoud Saliman of Rambam Health Care Campus is the first in Israel to insert an ultrasound device through a vein (without anesthesia) to safely diagnose a patient suffering from atrial fibrillation (AFib). High-risk patients cannot have anesthesia or blood thinners.

More details about Israel’s IdentifAI Genetics (see previously) and its Hoobari blood test invented by Tel Aviv University’s Professor Noam Shomron. The test separates the DNA of a 10-week fetus from that of its mother and then checks it for mutations. Much safer than amniocentesis.

HAMA (see previously) is among the pioneering organizations in Animal Assisted Intervention in Therapy and Education in Israel. Many of the animals are rescued from abuse and neglect, and have in turn enriched humans suffering from trauma, deep loss, and abandonment.

The Ivory Dentin Graft™ dentin graft material from Israel’s Ivory Graft has just received the European CE Mark for use in the repair or augmentation of bone defects. Its similarity to bone makes it an ideal grafting material, e.g., in dental procedures.

OrCam Learn (see previously) is a voice-activated, interactive handheld device designed for people with learning challenges. It combines AI with a high-resolution visual sensor, and laser capture. It reads text aloud from any surface, listens to the reader and provides feedback. And much more.

Scientists at Israel’s Technion Institute have developed a nano-material that can deliver different toxic cancer therapies directly to tumors, without harming healthy cells. Robot chemistry was used to test different materials. The breakthrough can vastly reduce chemo side effects.

For the first time, the World Health Organization came to Israel to hold its 72nd session of the WHO Regional Committee for Europe. 53 nations attended the conference from Sep 12-14 during which Israel signed bilateral health cooperation deals with Germany, Croatia, Cyprus, and Kazakhstan.

Israel’s Matricelf (see previously) was placed third out of 17,000 contenders for the 2022 Startups World Cup in San Francisco. Matricelf developed the technology for the heart 3D-printed by Tel Aviv University scientists in 2019 (see ).

Israel’s Beyeonics Vision (see previously) now has European as well as US approval for its Beyeonics One™ ophthalmic exoscope. The augmented reality (AR) surgical headset gives eye doctors vastly enhanced abilities when performing eye surgery (e.g., cataracts).

Israel’s Kahun (see previously) has expanded from merely a Covid-19 diagnosis system to a full “digital medical advisor”. Its XAI engine bases its clinical reasoning decisions on Kahun’s proprietary map of over 30 million evidence-based medical insights.